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Abstract
Background: Chlorotoxin (TM601), a scorpion venom- derived 36-AA peptide, is an experimental drug against
recurrent glioma with tumor specificity but unknown route of intracellular distribution. The aim of this study was
to evaluate the route of entry and cellular localization of TM601 in glioma cells.
Results: We have found that in human gliomas, lung carcinoma and normal vascular endothelial cells, TM601
localizes near trans-Golgi while in normal human dermal fibroblasts (NHDF) and astrocytes it is dispersed in the
cytoplasm. The uptake of TM601 by U373 glioma cells is rapid, concentration and time dependent, not affected by
inhibitors such as filipin (caveolae-dependent endocytosis) and amiloride (non-selective macropinocytosis), but
significantly affected by chlorpromazine (clathrin-dependent intracellular transport of coated pits) resulting in
intracellular build-up of the drug and clathrin near the Golgi. In contrast, TM601 uptake by NHDF cells was
significantly affected by amiloride indicating that macropinocytosis is the dominant uptake route of TM601 in these
cells.
Conclusions: In conclusion, we found a distinct cellular localization pattern and uptake of TM601 by glioma cells
differing from that found in normal cells. Further insight into the cellular processing of TM601 should assist in the
development of effective anti-glioma therapeutic modalities.
Background
TM601 is a pure, chemically synthesized chlorotoxin of
36 amino acids which was first purified from the venom
of the scorpion Leiurus quinquestriatus. For clinical
development, chlorotoxin has been manufactured using
solid phase chemical syntheses, and it is called TM601.
It is known that TM601 has a similar homology and
structure as other venom peptides and in that resembles
members of the family of small disulfide-rich proteins
characterized by a knotted topology [1]. It was first
found to be an inhibitor of small conductance chloride
channels [2]. Both inhibition of invasion and inhibition
of metalloproteinase-2 (MMP-2) activity have been pre-
viously observed in glioma cells treated with chlorotoxin
[3,4]. Recently, a similar in vitro finding was reported
for human umbilical vein endothelial cells (HUVEC)
treated with TM601 [5]. TM601 is not cytostatic or
cytotoxic to tumor or vascular endothelial cells in vitro.
However, potent pleiotropic anti-angiogenic effects of
TM601 in vivo were reported. These effects include a
decreased tumor growth in chick chorioallantoic mem-
brane assay as well as decreased intra-tumoral hemoglo-
bin levels. In addition, it was shown that TM601
injected intravenously in vivo in mice significantly
decreased new blood vessel growth [5].
Recently, the in vitro and in vivo tumor targeting
properties of the peptide have been shown to be
retained following conjugation to a near-infra red fluor-
escent dye [6], nanoparticles [7,8], and polymers [9].
Similar observations were made in in vivo animal mod-
els using chlorotoxin conjugated to
131Iodine-(
131I- )
[10]. The nanoparticles with multiple chlorotoxin mole-
cules on their surface have shown enhanced inhibition
of invasion in vitro compared to monomeric chlorotoxin
[11]. The tumor targeting properties of TM601 conju-
gated to
131I -administered intravenously were evaluated
in Phase I clinical studies for solid tumors [12] and
locally in Phase II clinical studies of recurrent glioblas-
toma multiforme [13]. These studies showed that after
the local delivery of
131I-TM601 to the resection cavity,
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tumor cavity site for several days [13,14].
TM601 does not bind to non-transformed cells such
as human neurons, astrocytes and fibroblasts as well as
to over 15 normal human tissues [5,15]. However, using
histochemical methods, TM601 binds selectively to
glioma cells and other tumors of neuroectodermal origin
[15]. Furthermore, recently, annexin A2 was identified as
a binding partner for TM601 in multiple human tumor
cell lines and normal human endothelial cells HUVEC
[16]. Despite its known specificity for tumor cells
including glioma, the exact route of entry, intracellular
trafficking, and cellular localization of TM601 in glioma
cells compared to control normal cells has not yet been
resolved. In this study we evaluated TM601 cellular
entry by three different endocytic pathways. We used
chlorpromazine, an inhibitor of clathrin-mediated intra-
cellular transport of clathrin-coated pits, filipin, an inhi-
bitor of cholesterol-dependent caveolar cell transport,
and amiloride, an inhibitor of Na+/H+ exchange in
ligand-independent, non-selective transport by
macropinocytosis.
The amiloride-sensitive, ligand-independent macropi-
nocytosis involves indiscriminant sampling of large
extracellular volumes by large endocytic vesicles, macro-
pinosomes. However, both filipin and chlorpromazine
affect formation of small endocytic vesicles containing
i n v o l u t e ds p e c i f i cp l a s m am e m b r a n ed o m a i n ss u c ha s
the cholesterol rich domain of caveolae or other
domains of receptors. Therefore, the activities of filipin
and chlorpromazine substantially differ from that of
amiloride by having a selective effect on ligand-depen-
dent endocytosis [17-21].
Here we provide evidence that TM601 enters glioma
cells mainly via a clathrin-dependent chlorpromazine-
sensitive pathway leading to the Golgi, whereas in nor-
mal fibroblasts the predominant transport mechanism
for TM601 is macropinocytosis. In addition, we show
that the cellular localization and processing of TM601
in glioma cells differs profoundly from that found in
normal astrocytes and fibroblasts but is similar to nor-
mal human endothelial cells.
Results
Time and Dose Response and Cellular Localization of
TM601
To asses TM601 time and dose response, human glioma
U373 cells were incubated with 0, 3, 6, and 10 μM
TM601 for 1 h or 24 h, and followed by immunocyto-
chemistry and confocal microscopy (Figure 1). TM601
fluorescence intensity of glioma cells showed that
TM601 entered cells in a dose-dependent (Figure 1)
manner showing a linear increase in cell’s fluorescence
intensity with increased concentrations of TM601 at 1 h
and 24 h incubation times. This increase was also
observed at 25 and 50 μM concentrations of TM601.
The levels of TM601 were similar at 1 h and 24 h at
any given concentration (Figure 1). When additional
earlier time points, e.g., 10 and 30 minutes were tested
using 10 μM TM601 concentrations, we observed that
TM601 achieved its maximum cellular level and pla-
teaued within first 30 minutes of incubation. The uptake
of TM601 by U373 glioma was rapid and occurred only
under physiological (37°C, 5% CO2) conditions. There
was no TM601 detected in the cells when they were
either incubated at 4°C, or at 37°C, in the absence of 5%
CO2.
TM601 Cellular Localization: Immunocytochemistry
The confocal evaluation of human glioma cells (U373
and U87) treated for 24 h with 10 μM TM601, detected
T M 6 0 1n e a rt r a n s - G o l g i( F i g u r e2 A ,B ,C ,D ) .G o l g i n -
97, a 97 kDa member of the granin protein family is a
peripheral membrane protein localized on the cytoplas-
mic face of the Golgi apparatus and it is unique to the
Golgi apparatus of most vertebrate species. Therefore,
Golgin-97 was used as a marker for the identification of
the Golgi apparatus in the glioma and normal cells.
Similar to glioma cells, normal human umbilical vascu-
lar endothelial (HUVEC) cells showed TM601 localiza-
tion near the trans-Golgi membranes (Figure 2E, F).
However, following the same treatment of normal
human dermal fibroblasts (NHDF) or normal human
astrocytes (NHA) using 10 μM TM601 for 24 h, TM601
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Figure 1 TM601 Time and Dose Response in U373 glioma cells.
TM601 dose response of U373 glioma incubated with 0, 3, 6, and
10 μM TM601 for 1 h or 24 h and evaluated by
immunocytochemistry and confocal microscopy in n = 3-4
experiments. The fluorescence intensity/cell was obtained studying
50-100 cells/each concentration of TM601 (at 1 h and 24 h) in each
experiment. Presented are means and SD for each TM601
concentration.
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Figure 2 Cellular localization of TM601 and Golgin-97 by immunocytochemistry. Immunocytochemistry followed by confocal microscopy
showed cellular localization of TM601 (red) in relation to Golgin-97 (green) and nucleus (blue) in human cells: U373 glioma (A, B), U87 glioma
(C, D), normal umbilical vascular endothelial HUVEC (E, F), normal astrocytes NHA (G, H, I) and normal fibroblast NHDF (J, K, L) cells. The figure
shows a similar Golgi localization of TM601 in gliomas (U373, U87) and HUVEC cells but in NHA and NHDF cells, TM601 is seen away from the
trans-Golgi. Shown are data representative of n = 8 experiments. The scale bars on the confocal images = 10 μm, magnification 1890 × (A, C, E,
H, I, K, L), 4410 × (B, D, F), 630 × (G, J).
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Page 3 of 13appeared as diffused staining in the cytoplasm, distant
from the trans-Golgi area (Figure 2G, H, I, J, K, L).
Therefore, TM601 cellular localization in these two nor-
mal cell types, NHA and NHDF, differed profoundly
from what was observed in glioma cells and normal
HUVEC cells. The negative non-TM601 treated cell
controls showed no staining.
TM601 Cellular Localization: Direct Fluorescence
A similar cellular localization and a granular staining of
TM601 as seen using immunocytochemistry, were also
observed in live cells using a direct fluorescence evalua-
tion of 24 h Alexa-488 conjugated TM601 (TM601-488)
treated cells followed by the treatment with the BODIPY
TR C5-ceremide sphingolipids complex to BSA (Golgi
complex-Texas (TX) Red -Golgi tracker). The negative
non-TM601 treated cell controls showed no staining.
The evaluated tumor cell lines such as human glioma
U373, human lung carcinoma A549 (Figure 3B, C) and
normal HUVEC cells (data not included) showed peri-
nuclear localization of TM601 in the Golgi area confirm-
ing the previous observation by immunocytochemistry.
Again, in the normal human NHDF cells TM601-488
was detected in the cytoplasm away from the Golgi area
(Figure 3A).
Further evaluation of a granular TM601 localization in
the Golgi area in glioma cells, involved studies of acidic
organelles such as lysosomes and/or late endosomes
often positioned near the Golgi apparatus and the
nucleus. The human glioma U373 cells were compared
with normal human NHDF and NHA cells following the
treatment with TM601-488 and Lyso-Tracker-Red DND
99 and evaluation of direct fluorescence. The
colocalization of TM601 and LysoTracker was higher in
human glioma cells when compared to both normal
human astrocytes and fibroblasts showing merged red
and green fluorescence (Figure 4). This finding indicated
a higher level of TM601 in lysosomes of glioma cells
than in normal NHA and NHDF cells suggesting that
there may be different TM601 endocytic pathways in
glioma versus normal fibroblasts and astrocytes. To
further study this difference between TM601 uptake by
U373 glioma and normal NHDF cells we used three dif-
ferent inhibitors of endocytosis: filipin, chlorpromazine
and amiloride.
Endocytosis of TM601: Studies with Inhibitors
Filipin
Human U373 glioma cells (Figure 5A, B, C, D, E, F) and
normal NHDF fibroblasts (data not shown) treated with
or without filipin followed by either TM601-488 or
TM601 at 10 μM concentration for 1 h or 24 h were
evaluated by confocal microscopy following either
immunocytochemistry (Figur e5 C ,F )o rd i r e c tf l u o r e s -
cence (Figure 5A, B, D, E). Both approaches did not
show a detectable effect of filipin on the level of fluores-
cence of TM601 treated cells. However, when U373
glioma cells were evaluated using positive controls of
epidermal growth factor (EGF) or cholera toxin uptake
(known to be affected by filipin treatment [17,22]), the
inhibitory effect of filipin on the level of EGF and cho-
lera toxin staining was observed as expected (Figure 5A,
B, D, E).
Chlorpromazine and Amiloride
Glioma cells Treatment of U373 glioma cells with
TM601-488 or TM601 at 10 μM concentration in
NHDF normal  
fibroblast cell
A549 lung carcinoma cell U373 glioma cell A B C
Golgi-
TrackerRed
TM601-488
TM601-488
TM601-488 Golgi-
TrackerRed
Golgi-
TrackerRed
Figure 3 Cellular localization of TM601-488 and Golgi complex-TX Red (Golgi-Tracker) by direct fluorescence. Images of live cells and cellular
localization of TM601-488 (green) in relation to the Golgi-complex-Texas-Red (red) detected by direct fluorescence in NHDF normal human fibroblasts
(A), U373 glioma (B), and A549 lung carcinoma (C). The figure shows similar perinuclear localization in the Golgi area of TM601-488 in glioma U373 and
lung carcinoma A549, but in NHDF cells, TM601-488 is seen in the cytoplasm away from the Golgi area and outside the cell membrane. The data are
representative of n = 9 experiments. Scale bars = 10 μm, magnification 1260 × (A), 630 × (B), 2000 × (C).
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Page 4 of 13presence or absence of chlorpromazine 10 μg/ml, an
inhibitor of clathrin-mediated transport, for 1 h (data
not shown) or 24 h (Figures 6, 7, 8) affected the intra-
cellular transport of TM601 as evaluated by direct fluor-
escence (data not shown), immunocytochemistry
(Figures 6D, H, 7) or Western blotting (Figure 8). Con-
trols treated with chlorpromazine alone at 10 μg/ml
showed no toxicity. When U373 glioma cells were evalu-
ated using transferrin-Texas (TX) Red as a positive con-
trol [23], the inhibitory effect of chlorpromazine on the
level of transferrin staining was observed as expected
(Figure 6C, G). Dual immunocytochemistry with anti-
TM601 and anti-clathrin light chain (LC) antibodies
showed that in TM601 treated controls clathrin was
detected as a wide-spread punctate staining in the cyto-
plasm and at the perinuclear region, while TM601 was
observed only at the perinuclear region (Figure 7A).
However, in the combined chlorpromazine and TM601
treated cells, both clathrin and TM601 appeared to
accumulate at the perinuclear region (Figure 7B, C).
This was expected based on the known chlorpromazine
NHA Astrocytes NHDF Fibroblasts U373 Glioma
merge
U373 Glioma
LysoTracker -Red 
U373
TM601-488
U373
B A C
F D
E
Figure 4 Cellular colocalization of TM601-488 and Lyso-
Tracker-Red DND 99 by direct fluorescence. Images of live cells
and cellular colocalization of TM601-488 (green) and Lyso-Tracker-
Red DND 99 (red) detected by direct fluorescence in NHDF normal
human fibroblasts (A), NHA normal human astrocytes (B), and U373
human glioma (C) using the Colocalization Tool (as described in the
Methods). An overlay mask (white pixels) placed on each image
visualizes the colocalization of pixels above the background
threshold showing the highest level of white pixels in the U373
glioma (C). The following three fluorescent color channels were
used: green (TM601-488), red (Lyso-Tracker- Red), and yellow (merge
of red and green fluorescence) to determine the extent of
colocalization of TM601 and LysoTracker by confocal microscopy.
The merge red and green fluorescence in glioma cells (F) was
compared to the controls of TM601-488 (D) alone or LysoTracker
Red (E) alone. The images in D, E, and F are representative of n = 7
experiments. The Colocalization Tool in A, B, C was used in one out
of 7 experiments evaluating total of 14-29 cells in 3 fields. Scale bars
=1 0μm, magnification 630 ×.
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Figure 5 Effect of Filipin on uptake of TM601, CholeraToxin
and EGF by glioma cells. Images of live U373 glioma cells treated
with 1 μg/ml CholeraToxin B-555 (A, D), or 1 μg/ml EGF-TX-Red (B,
E), or immunocytochemistry of U373 glioma treated with 10 μM
TM601 (C, F) in presence or absence of filipin (5 μg/ml). There was
no visible effect of filipin treatment on the level or pattern of
staining for TM601, but EGF and cholera toxin staining was affected.
Data are representative of total n = 4 - 5 experiments. Scale bars =
10 μm, magnification 1890 ×.
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Figure 6 Effect of chlorpromazine and amiloride on uptake of
TM601, dextran and transferrin by glioma cells. Images of U373
glioma cells (treated with: dextran-TX at 1 mg/ml (A), dextran-TX at
1 mg/ml in presence of amiloride 300 μM (E), TM601-488 10 μM (B),
TM601-488 10 μM in presence of amiloride 300 μM (F), transferrin-
TX at 35 μg/ml (C), transferrin-TX at 35 μg/ml in presence of
chlorpromazine 10 μg/ml (G), TM601 10 μM (D) and TM601 10 μM
in presence of chlorpromazine 10 μg/ml (H). Direct fluorescence is
shown in A, B, C, E, F, G and immunocytochemistry in D, H. The
level of staining of both controls, dextran and transferrin, were
decreased by amiloride or chlorpromazine, respectively. Data are
representative of total n = 3 experiments. Scale bars = 10 μm,
magnification 1890 ×.
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Page 5 of 13effect on the clathrin-mediated intracellular transport of
proteins resulting in their accumulation near the Golgi
(Figure 7E). The cellular colocalization of TM601 (red)
and clathrin light chain (green) was detected by immu-
nofluorescence in U373 glioma cells using the Colocali-
zation Tool as shown in Figure 7D and 7F.
Cells treated with TM601 and chlorpromazine showed
a 5 fold significant (p < 0.005) enhancement of TM601
levels when compared to the TM601 treated controls as
seen on the Western blot (Figure 8A, B). This finding
confirmed the data obtained from immunocytochemis-
try. A similar study using a combined treatment of 10
μM TM601 or TM601-488 and 300 μM amiloride, an
inhibitor of ligand -independent and non-selective
transport by macropinocytosis, had no effect on TM601
cellular transport in glioma cells seen by direct fluores-
cence (Figure 6B, F) or on Western blot (Figure 8A).
Western blot data were consistent when cell lysates
were prepared from either trypsinized (Figure 8) or
scraped cells (data not shown). However, when U373
glioma cells were treated with dextran-Texas (TX) Red
as a positive control the inhibitory effect of amiloride on
the level of dextran staining was observed as expected
[21] (Figure 6A, E).
Normal fibroblast cells Normal NHDF cells incubated
with 10 μM TM601-488 for 24 h in presence of 300 μM
amiloride, showed decreased fluorescence by confocal
microscopy. Lysates of normal NHDF cells incubated
with 10 μM TM601 for 24 h in presence of 300 μM
amiloride showed a 2 fold significant (p < 0.05) decrease
in TM601 levels by Western blotting when compared to
TM601 treated controls (Figure 9A, B). Controls treated
with amiloride alone at 300 μM concentrations showed
no toxicity. A similar study using a combined treatment
of 10 μM TM601 and chlorpromazine at 10 μg/ml
showed only a small and not significant effect (Figure
9A). These observations were consistent whether cell
lysates were prepared from trypsinized (Figure 9) or
scraped cells (data not shown).
Discussion
In this study we provide data showing the cellular
uptake, trafficking and localization of TM601 in glioma
cells. We found that TM601 uptake by glioma cells
resembles that of normal umbilical vascular endothelial
cells, but is different from the one seen in normal astro-
cytes and fibroblasts. We have observed repeatedly, that
TM601 enters glioma cell rapidly within a few minutes,
and localizes in the perinuclear Golgi region, under
strict physiological conditions, 37°C, 5% CO2, typically
required for the fast (1-2.5 minutes) clathrin-mediated
transport [24-26]. Clathrin-mediated endocytosis
involves the concentration of high-affinity trans-mem-
brane receptors and receptor- bound ligands into
“coated pits” and adaptor protein-2 (AP-2) mediated cla-
thrin binding to coated pits, followed by their matura-
tion, fission and formation of clathrin-coated vesicles
(CCVs). These are the major carriers for protein and
lipid cargo at the plasma membrane, the trans-Golgi
network (TGN), and the endosomal system [18,27]. Cla-
thrin, a triskelion structure, is composed of three copies
of clathrin heavy and up to three clathrin light chains
(LC) critical for the trafficking between TGN and the
endosomal system [28].
When evaluating the intracellulr trafficking of TM601
in glioma cells we focused on the clathrin LC and used
dual staining for clathrin LC and TM601. While we
found clathrin molecules widespread as a punctate
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Figure 7 Cellular colocalization of TM601 and clathrin light
chain in chlorpromazine treated U373 glioma cells.
Immunocytochemistry of U373 glioma cells followed by confocal
microscopy showed cellular localization of TM601 (red) and clathrin
(green) in relation to the nucleus (blue) in TM601 treated control (A)
and in TM601 and 10 μg/ml chlorpromazine treated cells (B, C). The
chlorpromazine treatment resulted in accumulation of TM601 in the
perinuclear region (B, C). The schematic illustration of
chlorpromazine action on TM601 uptake is shown (E). The cellular
colocalization of TM601 (red) and clathrin light chain (green) was
detected by immunofluorescence using the Colocalization Tool (D
and F) as described in the Methods. An overlay mask (white pixels)
placed on each image visualizes the colocalization of pixels above
the background threshold (D and F). It shows that more of white
pixels were observed in TM601 and 10 μg/ml chlorpromazine
treated (F) than in TM601 (D) only treated glioma cells. This is due
to a higher level of TM601 in the presence of chlorpromazine
resulting in higher red immunofluorescence which merged with
green immunofluorescence derived from clathrin. The following
three fluorescent color channels were used: red (TM601), green
(clathrin light chain), and yellow (merge of red and green
fluorescence) to determine the extent of colocalization of TM601
and clathrin light chain by confocal microscopy. The merged red
and green fluorescence in glioma cells (C) was compared to the
controls of TM601 (red insert in C) alone or clathrin light chain
(green insert in C) alone. Data are representative of total n = 3
experiments. The Colocalization Tool in D and F was used in one
out of 3 experiments evaluating total of 15-26 cells in 3 fields. Scale
bars = 10 μm, magnification 3780 ×.
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Page 6 of 13staining most likely being part of clathrin-coated vesi-
cles, the larger concentration of clathrin LC molecules
was together with TM601 in the Golgi and adjacent
perinuclear region. The accumulation of clathrin and
TM601 in the perinuclear region of glioma cells may be
the result of TM601 transport by clathrin-coated vesi-
cles to the TGN.
Interestingly, we found a similar perinuclear, trans-
Golgi localization of TM601 in normal human umbilical
vascular endothelial cells, which was profoundly differ-
ent from normal human fibroblasts and astrocytes in
which TM601 was localized away from the trans-Golgi
area. Our findings agree with two recent reports, show-
ing that TM601 affects certain tumor type cells
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Figure 8 Effect of chlorpromazine or amiloride on TM601 uptake by U373 glioma cells. Western blots of TM601 (10 μM) - treated U373
glioma cells in presence or absence of 300 μM amiloride or 10 μg/ml chlorpromazine (A). Lysates of trypsinized cells were used at 20-25 μg
protein. Beta-actin was used as a sample loading control (representative data of n = 3). Chlorpromazine (Chlorp) affected the uptake of TM601
(TM) (A, B) while amiloride had no effect on TM601 level in glioma cells (A). The statistically significant 5 fold (p < 0.005) effect of
chlorpromazine is shown on the graph (B). The data represent n = 3 experiments using duplicate samples/per experiment (total of 6 samples).
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Figure 9 Effect of chlorpromazine or amiloride on TM601 uptake by NHDF fibroblasts. Western blots of TM601 (10 μM) - treated NHDF
fibroblasts in presence or absence of 300 μM amiloride or 10 μg/ml chlorpromazine (A). Lysates of trypsinized cells were used at 9-12 μg
protein. Beta-actin was used as a sample loading control (representative data of n = 3). The statistically significant 2 fold (p < 0.05) effect of
amiloride (Amilor) on TM601 (TM) level is shown on the graph (B). The chlorpromazine had a small, statistically not significant effect on TM601
level (A). The data represent n = 3 experiments using duplicate samples/per experiment (total of 6 samples).
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Page 7 of 13(including glioma) and vascular endothelial cells in a
similar way (binds to annexin A2 and inhibits cell
migration), but not the other normal human cells [5,16].
Therefore, a similar endocytotic pathway for the recep-
tor-TM601 complex may exist in tumor cells and vascu-
lar cells.
To further evaluate TM601 localization in glioma cells
we directed our focus towards acidic organelles such as
lysosomes and/or late endosomes found in the perinuc-
lear region near the Golgi. Using dual staining of live
cells with fluorescent TM601 and Lysotrackers, pre-
viously used by others in studies of cellular internaliza-
tion [29] we observed a higher colocalization of TM601
and Lysotrackers in glioma cells than in normal astro-
cytes as well as fibroblasts. This finding supports pre-
vious [15,16] and current observations that binding,
uptake and cellular processing of TM601 in glioma cells
all differ from those observed in normal astrocytes and
fibroblasts.
To evaluate which endocytic pathway is utilized by
TM601 in glioma we used three inhibitors: filipin, chlor-
promazine and amiloride known to interfere with the
specific stages of three different endocytic pathways and
compared their effect on the level of TM601 in glioma
using fibroblasts as normal controls. Filipin, a sterol-
binding agent disrupts and damages structure and func-
tion of caveolae, a sub-type of lipid raft sensitive to cho-
lesterol depletion [17,25]. It also inhibits caveolae-
mediated endocytosis involving one of the types of cho-
lesterol and sphingolipid-rich microdomains. Filipin
showed no visible effect on uptake of TM601 by glioma
or fibroblast cells when compared to the positive con-
trols as measured by immunocytochemistry or direct
fluorescence. As positive controls we used cholera toxin
with caveolae binding specificity (gangliosides of lipid
raft) and EGF ligand protein of a similar molecular size
as TM601 which can be internalized through the caveo-
lar or raft/caveolar pathway [22,27,30]. While filipin,
which specifically interferes with the cholesterol-depen-
dent caveolar transport, showed an inhibitory effect on
internalization of cholera toxin and EGF in our studies,
it did not affect TM601 staining intensity or pattern.
However, the possibility of filipin having some effect
on TM601 uptake cannot be completely excluded since
it was shown previously that inhibition of glioma matri-
gel invasion by recombinant chlorotoxin His-Cltx may
be mediated by a filipin sensitive mechanism [3]. The
reduction in matrigel invasion by His-Cltx was postu-
lated to be at least in part mediated by filipin, and possi-
bly involving the effect of filipin on internalization of
His-Cltx bound to MMP-2 by caveoli. It is possible that
TM601, unlike His-Cltx, binds to a target localized in a
different region of the lipid rafts that is not sensitive to
filipin. Finally, there may also be a difference between
His-Cltx, and TM601 in their capacity to bind molecules
such a MMP-2 believed to be associated with the cho-
lesterol-rich areas of the lipid rafts. Therefore, the full
elucidation of the effect of filipin on TM601 endocytosis
requires further investigation.
To study the clathrin-dependent endocytic pathway of
TM601 cellular uptake we used chlorpromazine which
belongs to the cationic amphiphilic class (CAD) and
phenothiazine class of drugs for mental disorders and is
an inhibitor of the clathrin-coated pit -pathway. Phe-
nothiazines were reported to inhibit clathrin-dependent
endocytosis at the step of progression from type 2
coated pits to type 3 coated pits, [20]. As reported pre-
viously, chlorpromazine does not affect the initial
uncoating of coated vesicles and therefore, allows cells
to internalize cholera toxin [27], an observation also
true for TM601. However, chlorpromazine is known to
cause a loss of coated pits and associated receptors from
the surface of the cell, and the accumulation of clathrin
and AP-2 in the endosomal compartment [27,31-33].
Combined TM601 and chlorpromazine led to the accu-
mulation of clathrin and TM601 in the perinuclear
region corresponding to the endosomal compartment as
well as significantly enhanced TM601 levels on Western
blots in glioma cells. However, in normal fibroblasts
(selected as a normal cell control for this study) this
effect was less pronounced. As shown previously [27],
the accumulation of coated endosomes following CAD
treatment disrupts further processing of cholera toxin to
the Golgi apparatus as observed also by us for TM601.
Using the Colocalization Tool we observed that immu-
nofluorescence of clathrin light chain (green) and
TM601 (red) showed overlap at the Golgi. The observed
overlap was much more pronounced in cells treated
with combined chlorpromazine and TM601 than with
TM601 alone, because of accumulation of TM601 (red)
levels at the Golgi. The colocalization of clathrin light
chain with TM601 indicates that TM601 is internalized
in clathrin coated vesicles during endocytosis. Future
studies are planned to further evaluate and confirm cla-
thrin-mediated endocytosis of TM601 in glioma cells by
inhibiting this pathway using specific siRNAs against
clathrin heavy chain and vectors encoding dominant
negative mutant forms of dynamin or Epsin.
While chlorpromazine showed only a small and not
significant effect on uptake of TM601 by fibroblasts,
amiloride, an inhibitor of Na+/H+ exchange in ligand-
independent, non-selective transport by macropinocyto-
sis, had a significant inhibitory effect on TM601 uptake.
In contrast, amiloride had no effect on TM601 uptake
by glioma cells. Macropinocytosis which occurs in many
cells accompanies the signal-stimulated membrane ruf-
fling resulting in formation of actin-driven membrane
protrusions. The protrusions collapse and fuse with the
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macropinosomes, which can sample large volumes of
extracellular milieu [19]. Caveolae-mediated or clathrin
mediated endocytic pathways differ substantially from
macropinocytosis because they result in the formation
of smaller vesicles containing involuted selective
plasma-membrane receptor domains. Based on the stu-
dies described above, a different endocytic pathway
appears to be involved in the internalization of TM601
into glioma cells than normal fibroblasts. The TM601
receptor mediated endocytosis was observed for glioma
cells while a non-receptor mediated pathway dominated
in fibroblasts. In addition, we found that the uptake of
TM601 into fibroblasts and normal astrocytes may be
r a p i d l yf o l l o w e db yaT M 6 0 1r e l e a s ea so b s e r v e do n
confocal images. Therefore, levels of TM601 in fibro-
blasts and astrocytes may vary from cell to cell at a
given point in time. The cellular localization of TM601
was similar in normal human fibroblasts and normal
human astrocytes, leading us to believe that a similar
endocytic pathway may be responsible for TM601
uptake in these two types of normal human cells.
A so b s e r v e dp r e v i o u s l yb yV e i s e he ta l[ 6 ]t u m o rc e l l
specific binding was substantially higher using chloro-
toxin conjugated with Cy5.5 than with unconjugated
molecule suggesting that the Cy5.5 moiety may improve
tumor-specific targeting. We have made a similar obser-
vation with Alexa-488 conjugated TM601 and the
monomeric molecule. We observed that TM601-488
fluorescence persists much longer than that of the
monomeric TM601. Our data in glioma cells showing
TM601 being taken up by clathrin-mediated endocytosis
for processing into lysosomes at the endosomal com-
partment suggests that inducing structural changes to
monomeric TM601 molecule by conjugation with
Alexa- 488 or Cy5.5 or nanoparticles may affect its
endocytic pathway and lysosomal degradation, protect-
ing its activity and extending its retention in the glioma
cells.
Conclusions
In summary, our observations showed a distinct cellular
localization pattern and uptake of TM601 by glioma
cells differing from that found in normal cells. This
finding may assist in further development of experimen-
tal strategies leading to identification of additional cellu-
lar target molecules for TM601.
Methods
Cells
Three human tumor cell lines: human glioblastoma
grade III astrocytoma U373-MG, human glioblastoma,
astrocytoma U87-MG, and human lung carcinoma A549
(American Type Culture Collection [ATCC; Manassas,
VA) and three normal human cell lines: normal human
dermal fibroblasts (NHDF) and normal human astro-
cytes (NHA) both from (Cambrex Bio Science Walkers-
ville, Inc, Baltimore, MD), and normal human umbilical
vein endothelial (HUVEC) cells (ScienCell Research
Labs, San Diego, CA), were used in this study. U373,
U87 and A549 cells were grown at 37°C in 5% CO2,i n
Minimum Essential Medium (MEM) supplemented with
10% heat-inactivated fetal bovine serum (FBS) and 2
mM L-glutamine, penicillin, and streptomycin, NHA
cells were grown in astrocyte basic medium (ABM)
(Clonogenics Medium BulletKit) supplemented with
astrocyte growth supplement, 5% FBS, penicillin, and
streptomycin (Lonza Walkersville, Inc. Walkersville
MD), HUVEC cells were grown in vascular endothelial
cell medium containing 5% FBS, penicillin, streptomycin
and Endothelial Cell Growth Supplement (ScienCell).
TM601 and TM601 antibodies
TM601 (7.6 mg/ml) was obtained from Peptisyntha,
Torrence, CA. The TM601 peptide was a chemically
synthesized 36-amino acid peptide containing the same
amino acid sequence and four intramolecular disulfide
bonds as chlorotoxin. TM601 was synthesized by solid
phase chemical synthesis, refolded, and lyophilized. The
peptide was purified to greater than 95% purity [5,16].
TM601-488 (1.5 mg/ml) fluorescently labeled using
Alexa Fluor 488 succinimidyl ester (Invitrogen, Carlsbad,
CA) was obtained from TransMolecular, Inc., (Cam-
bridge, MA).
Anti-TM601 antibodies (1.19 mg/ml) obtained from
TransMolecular, Inc., (Cambridge, MA), were raised in
rabbits immunized to a conjugate between TM701 and
keyhole limpet hemocyanin. Tyrosine 29 in TM601 is
replaced by a phenylalanine residue in TM701. The rab-
bit serum from the immunized mice was purified over a
protein A column, followed by an affinity purification
step using a TM601-Affi-gel 10 affinity column. The
specificity of the TM601 antibody was tested with syn-
thetic TM601 using a Western blot [16].
Direct fluorescence and dual staining
Direct fluorescence studies were performed in live cells
plated (according to the manufacturer’s procedure) at
10-20 × 10
3 cells/per insert in MatTek’s glass bottom
dishes (MatTek Corp. Ashland, MA). Cells were allowed
to attach to the plates for 24 h using the MEM contain-
ing 10% FBS, astrocyte medium for NHA or endothelial
medium for HUVEC cells. Next, the growth medium
was removed and cells were either non-treated or trea-
ted for 24 h at 37°C in 5% CO2 with 10 μM TM601-488
in growth medium (appropriate for each cell type). Fol-
lowing the incubation with TM601-488, a second and/
or third fluorescent label was added to detect the Golgi
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location of TM601-488. Also, negative non-TM601-488
treated cell controls were evaluated either without fluor-
escent label (to exclude auto fluorescence) or with fluor-
escent label for detection of the Golgi complex or
lysosomes.
Staining for TM601-488 and Golgi complex
Following TM601-488 treatment, growth medium was
removed and plates were washed 2 times at room-tem-
perature with MEM without phenol red. This medium
was used throughout this procedure. The BODIPY TR
C5-ceremide sphingolipidsc o m p l e xt oB S Au s e da sa
Golgi-Tracker (Invitrogen, Carlsbad, CA) was then
added at 5 μM concentration for 30 min at 4°C to all
plates, to detect the Golgi complex. Next, the BODIPY
TR C5-ceremide-BSA was removed and cells were
rinsed twice with ice-cold medium, followed by addition
of room-temperature medium supplemented with 1%
FBS. The plates were placed in 37°C in 5% CO2 incuba-
tor for 30 minutes and fluorescence immediately evalu-
ated under confocal microscope.
Staining for TM601-488 and Lysosomes
Following TM601-488 treatment, media were removed
and plates washed 3 times with growth medium at
room temperature and Lyso-Tracker-Red DND 99 at 50
nM or LysoTracker Blue DND-22 at 50-75 nM concen-
tration (Invitrogen, Carlsbad, CA) were added to all
plates and incubated for 30 min at 37°C in 5% CO2. The
media containing LysoTracker was then removed, fresh
growth medium added, and fluorescence immediately
evaluated by confocal microscopy. In n = 3 experiments
a triple fluorescent labeling was used, including TM601-
488, followed by the BODIPY TR C5-ceremide-BSA (as
described above), and followed by LysoTracker Blue
DND-22 for a simultaneous detection of TM601, the
Golgi-complex and the lysosomes (data not shown).
Immunocytochemistry
Cells were seeded onto LabTekII culture chamber-2
(CC2) 8-glass slides (Nalge Nunc International, Naper-
ville, IL) at 20 × 10
3 cells/chamber in the appropriate
growth medium. After 24 hours incubation at 37°C in
5% CO2, the growth medium was removed and replaced
with fresh MEM medium with 1% FBS or with endothe-
lial medium for endothelial cells or ABM medium for
astrocyte cells. Cells were incubated with medium alone
or with addition of various concentrations of TM601
(for the dose response studies) at 37°C in 5% CO2 for 1
hour or 24 hours. Also, an additional time points such
as 10 and 30 minutes were tested as well using 10 μM
TM601. Following treatment with TM601, media were
removed and cells washed 2 times in phosphate buffered
saline (PBS) and fixed with 4% paraformaldehyde in PBS
for 15 minutes. Next, they were washed 2 times in PBS
and permeabilized and blocked using blocking buffer
containing 2% goat serum, 0.1% Triton X-100, 1%
bovine serum albumin (BSA) in PBS for 1 hour at room
temperature.
Affinity purified rabbit anti-TM601 antibody alone or
in combination with mouse monoclonal anti-Golgin-97
antibody which recognize a 97 kDa protein (Invitrogen,
Carlsbad, CA) or mouse monoclonal antibody to cla-
thrin light chain (Abcam, Cambridge, MA) were diluted
in blocking buffer to obtain the following concentrations
6 μg/mL (anti-TM601), 0.5 μg/mL (anti-Golgin-97), 2
μg/mL (anti-clathrin) and incubated in the chamber
slides for 1 hour at room temperature. The slides were
washed in 3 changes of PBS (5 minutes each) then the
secondary antibody(s) diluted in blocking buffer added
and incubated for 30 minutes at room temperature in
the dark. The Alexa Fluor 594-labeled goat anti-rabbit
IgG heavy + light (H+L) chain at 4 μg/ml (for TM601
detection) was added alone or in combination with
Alexa Fluor 488-label goat anti-mouse IgG (H+L) at 2
μg/ml (Invitrogen, Carlsbad, CA, USA) for a simulta-
neous detection of TM601 and either Golgin-97 or cla-
thrin- light chain. The negative non-TM601 treated cell
controls were evaluated using either combination of pri-
mary and secondary antibodies or only secondary anti-
bodies. Next, the chamber slides were washed 3 times
with PBS (5 minutes each), and one time with double
distilled water. The chambers were removed, slides
mounted in Vectashield containing DAPI nuclear coun-
terstain (Vector Laboratories, Inc, Burlingame, CA),
cover slipped and fluorescence evaluated using confocal
microscopy.
Confocal Microscopy
Micrographs of each sample were taken with a Leica
TCS SP5 laser scanning confocal microscope through a
63 ×/1.4NA or 100 ×/1.4 NA (Leica Microsystems, Ger-
many). 405 Diode, Argon, and HeliumNeon (HeNe) 594
laser lines were applied to excite the samples and tun-
able filters were used to minimize crosstalk between
fluorochromes. Gain, offset, and pinhole settings were
identical for all samples within each experiment. The
images by a differential interference contrast (DIC)
microscopy were also captured using the Argon laser
line. When applicable Image sections (Z- slices) at 0.5
-1 μm were captured and maximum projections were
prepared with the LAS AF software version 1.6.0 build
1016 (Leica Microsystems, Germany). All images were
taken at room temperature and using immersion oil.
The magnification for these images is 630 × or 1000 ×.
To obtain enlarged views of the cells 2 - 7 × zoom was
used therefore, increasing the final magnification, e.g.,
1890 × (for 3 × zoom with the 63 × lens) or 3780 × (for
6 × zoom with the 63 × lens), etc. The control plates
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and offset settings to exclude non-specific secondary
antibody and auto fluorescence.
Measurement and Quantification of TM601 Fluorescent
Signal
Analysis of each cell’s intensity of fluorescence for
TM601 was performed using Image Pro Plus version 5.0
(Media Cybernetics, Inc., Silver Springs, Maryland). The
control plates for TM601 treated cells were used to
establish the “Gain” for a given light and to exclude the
auto fluorescence. Individual cells were segmented using
“Area of interest “(AOI) selection tool and mean inten-
sity of TM601 signal was measured in objects 2 pixels
or greater in size. Results were exported to Microsoft
Excel and analyzed statistically.
Co-localization studies: TM601-488 and Lyso-Tracker-Red
DND 99 or TM601 and Clathrin light chain
The analysis for both studies evaluating direct fluores-
cence (TM601-488 and LysoTracker-Red DND99) or
immunofluorescence (TM601 and clathrin) was per-
formed using the Colocalization Tool provided by Leica
Application Suite (LAS) AF software version 1.6.0 build
1016 (Leica Microsystems, Germany). The resulting
graphs obtained from each study represent the group of
cells in the image. An overlay mask (white pixels) was
placed on each image to locate colocalized pixels above
the background threshold. In addition, in the colocaliza-
tion study of TM601-488 and Lyso-Tracker Red DND99
the identical background thresholds, as shown on scatter
plots, were set for each image to determine colocaliza-
tion percentage for individual cells, which were selected
with the “Region of Interest” (ROI) selection tool.
Studies with Inhibitors of endocytosis
Filipin
U373 glioma and normal NHDF cells were seeded in
either the LabTekII CC2 8-glass chamber slides at 20 ×
10
3 cells/chamber (for immunocytochemistry) or in
MatTek’s glass bottom dishes at 20 × 10
3 cells/per insert
(for direct fluorescence) and incubated overnight at 37°C
in 5% CO2 in growth medium containing 10% FBS. The
next day, cells were pre-treated with filipin complex
from Streptomyces filipinesis (Sigma-Aldrich, St. Louis
MO) at 1 μg/ml for 1 h at 37°C in 5% CO2 [34] or at 1-
5 μg/ml for 15 min at 4°C [3] followed by treatment
with 10 μM TM601 (for immunocytochemistry) or 10
μM TM601-488 (for direct fluorescence) for 1 h or 24 h
at 37°C in 5% CO2. All treatments were done using the
growth medium containing 1% FBS.
In addition, the effect of filipin on endocytosis of the
epidermal growth factor (EGF)- biotynylated complex to
Texas-Red streptavidin (TX-Red) at 1 or 10 μg/ml or
CholeraToxin subunit B-555 at 1 μg/ml (both from Invi-
trogen, Carlsbad, CA) were evaluated. EGF was selected
with a similar molecular weight (~6000 kDa) as TM601
(~4000 kDa). In these experiments cells were grown in
MatTek’s glass bottom dishes pre-treated with filipin at
1o r5μg/ml for 15 min at 4°C, followed by treatment
with either EGF-TX-Red or cholera toxin-555 (in pre-
sence or absence of filipin) for 10 min at 4°C, removal
of the reagents, washes and incubation of cells in growth
medium containing 1% FBS for 15 min at 37°C in 5%
CO2. The confocal evaluation of the cells’ direct fluores-
cence was initially performed after first 10 min incuba-
tion at 4°C with the reagents (cell surface detection) and
after final 15 min at 37°C incubation of cells (intracellu-
lar detection).
Amiloride and Chlorpromazine
The U373 glioma or normal NHDF cells were seeded in
either the LabTekII CC2 8-glass chamber slides at 20 ×
10
3 cells/chamber (for immunocytochemistry), in Mat-
Tek’sg l a s sb o t t o md i s h e sa t2 0×1 0
3 cells/per insert
(for direct fluorescence) or in 75 cm
2 flasks at 6 × 10
6
cells/flask (for Western blotting) and incubated over-
night in the growth medium with 10% FBS at 37°C in
5% CO2. The following day, the confluent cell mono-
layers were pre-treated for 30 min at 37°C in 5% CO2
incubator with 1% FBS supplemented medium alone or
with medium containing amiloride hydrochloride
hydrate (Sigma-Aldrich, St. Louis MO) at 300 μMo r
chlorpromazine hydrochloride (Sigma-Aldrich, St. Louis
M O )a t1 0μg/ml. Next, the reaction medium was
removed and replaced with 1% FBS supplemented
growth medium containing 10 μMT M 6 0 1o r1 0μM
TM601-488 alone for 1 h or 24 h at 37°C in 5% CO2 or
with addition of inhibitors (amiloride at 300 μMo r
chlorpromazine at 10 μg/ml) for the respective pre-trea-
ted cultures. Cell cultures were incubated for 1 h or 24
ha t3 7 ° Ci n5 %C O 2. At the end of the treatment, the
reaction medium was removed, cells washed 3 times
and either direct fluorescence was observed (MatTek’s
dishes) or cells were fixed and evaluated by immunocy-
tochemistry and confocal microscopy (chamber slides as
described above); or trypsinized or scraped, cell lysates
prepared and proteins evaluated by SDS/PAGE and
Western blotting (tissue culture flasks).
In addition, the effect of chlorpromazine and amilor-
ide on endocytosis of transferrin-Texas-Red (TX-Red) at
35 μg/ml according the protocol by Pho et al [23] or
dextran-TX [21] at 0.1 or 1 mg/ml (both from Invitro-
gen, Carlsbad, CA) were evaluated, respectively. Dextran
conjugate was selected with a similar molecular weight
(~3000 kDa) as TM601 (~4000 kDa). In these experi-
ments cells were grown in MatTek’s glass bottom
dishes. Endocytosis of transferrin was studied using con-
fluent cell monolayers that were pre-treated for 45 min
at 37°C in 5% CO2 incubator with 1% FBS supplemented
medium alone or with medium containing
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was removed and replaced with 1% FBS supplemented
growth medium containing 35 μg/ml transferrin alone
or with addition of chlorpromazine at 10 μg/ml for the
respective pre-treated cultures and incubated for 20
minutes at 37°C in 5% CO2. Endocytosis of dextran was
studied also using confluent cell monolayers that were
pre-treated for 30 min at 37°C in 5% CO2 incubator
with 1% FBS supplemented medium alone or with med-
ium containing amiloride 300 μM. Next, the reaction
medium was removed and replaced with 1% FBS supple-
mented growth medium containing 0.1 or 1 mg/ml of
dextran (21) alone or with addition of amiloride 300 μM
for the respective pre-treated cultures and incubated for
1o r2 4ha t3 7 ° Ci n5 %C O 2. At the end of the treat-
ment, the reaction medium from all cultures was
removed, cells washed 3 times and direct fluorescence
of cells treated with transferrin -TX or dextran-TX was
evaluated by confocal microscopy.
SDS/PAGE and Western blotting
Cell monolayers treated with TM601 in presence or
absence of amiloride or chlorpromazine were washed
three times with PBS, trypsinized (or scraped), resus-
pended in ice-cold PBS, cells centrifuged and pellets
washed 3 times in ice-cold PBS. Next, pellets were
resuspended in ice-cold lysis buffer A containing 25
mM Tris (pH 7.6), 75 mM NaCl, 1 mM DTT, and pro-
tease inhibitor mixture (Roche Diagnostics, GmbH,
Manenheim, Germany) and briefly sonicated at 4°C,
centrifuged at 14 000 rpm in 4°C for 20 min, and the
supernatants containing crude cytosolic fraction were
collected and saved on ice. The remaining pellets were
then resuspended in buffer B identical to buffer A with
addition of 1% Triton X-100, and lysed in room tem-
perature for 20 minutes. Next, the samples were centri-
fuged at 12 500 rpm in 4°C for 15 minutes,
supernatants containing crude soluble membrane frac-
tion were collected, combined with the first collected
supernatant and protein quantified using protein assay
kit and the manufacture’sp r o c e d u r eb yP i e r c eB i o t e c h -
n o l o g y ,R o c k f o r d ,I L .E q u a lp r o t e i nq u a n t i t i e so fe a c h
supernatant (lysate) were prepared for analysis by SDS/
PAGE under denaturing conditions and using DTT as a
reducing agent. The level of TM601 was then deter-
mined by Western blots as follows. The NuPAGE
Novex Bis-Tris Mini Gels were transferred in NuPAGE
transfer buffer (Invitrogen, Carlsbad, CA) on to 0.2 μm
polyvinylidene difluoride (PVDF) membrane (Invitrogen,
Carlsbad, CA) and blots incubated for 1 h at room tem-
perature in the blocking buffer containing 5% (w/v)
nonfat dry milk (Carnation) in Tris-buffered saline with
0.1% Tween-20 (TBST). Next, the blots were immuno-
blotted in TBST blocking buffer containing either
affinity-purified anti-TM601 at 2.4 μg/ml or mouse
monoclonal anti-beta-actin antibodies at 0.4 μg/ml
(Sigma-Aldrich, St. Louis MO, as a loading control, and
incubated overnight at 4°C. The blots were washed in
TBST buffer and incubated for 1 h at room temperature
with goat anti-rabbit peroxidase conjugated secondary
antibody at 1:20 000-1:50 000 (Jackson ImmunoResearch
Laboratories, Inc. West Grove, PA) to detect TM601 or
with sheep anti-mouse peroxidase conjugated anti-beta-
actin at 1: 2 000 (GE Healthcare UK Limited) to detect
beta-actin. After washes in TBST buffer, the blots were
developed using Super Signal WestPico chemilumines-
cent reagent (Pierce, Rockford, IL). The intensity of
TM601 bands for duplicate samples was captured using
the Gel Doc XR scanner (Bio-Rad, Hercules, CA) con-
nected to the charge-coupled device (CCD) camera for
capturing image. The volume density analysis of TM601
bands was performed using Quantity One (Bio-Rad)
quantitation software (version 4.6.3) subtracting the
density of the pixel in the background volumes from
each pixel in all sample volumes.
Statistical analysis
Statistical analysis was performed using the Microsoft
Excel Analysis Tool Pack (Redmond, WA). Descriptive
statistics (mean and SD) were obtained for cell’sf l u o r e s -
cence intensity in the studies of TM601-time and dose
response (n = 3-4 experiments) evaluating 50-100 cells/
per TM601 concentration at 1 h or 24 h. Also, mean and
SD was obtained for the relative intensity of TM601
bands evaluated by the western blotting (n = 3 experi-
ments) using duplicate samples. The F value for two sam-
ple variances was established and Student’st - t e s tw a s
used for the statistical comparison of the chlorpromazine
and amiloride effect on endocytosis of TM601. Differ-
ences were considered statistically significant at p < 0.05.
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